Skip to main navigation Skip to search Skip to main content

Rapid infliximab infusions are generally well-tolerated in children with inflammatory bowel disease

Research output: Contribution to journal › Letter › Other › peer-review

Original languageEnglish
Pages (from-to)94-95
Number of pages2
JournalJournal of Paediatrics and Child Health
Volume53
Issue number1
DOIs
Publication statusPublished - 1 Jan 2017

Cite this